Unraveling the sugar metabolism of Candida albicans to find new antifungal drugs KU Leuven
Candida albicans is an opportunistic fungal pathogen which infection rate became more frequent over the last years. Another problem is their rising resistance against the available antifungal drugs on the market, like fluconazole. Therefore, C. albicans is a relevant health problem and there is an urgent need for new antifungal drugs with a complete novel mode of action to counteract the spread of this fungus. To colonize the human body this ...